Macrogenics reported $615K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US $ 31343M 96M
AstraZeneca AZN:LN 387M 0M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Epizyme EPZM:US $ 0.02M 0M
Genmab GEN:DC DK 66M 0M
Geron GERN:US $ 0.32M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.62M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Xencor XNCR:US $ 0.6M 0M